Xtx Topco LTD Eli Lilly & CO Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $437,096 - $548,151	603 New	603 $545,000
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $2.61 Million - $3.07 Million	-4,965 Reduced 79.68%	1,266 $737,000
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $2.71 Million - $3.73 Million	6,231 New	6,231 $3.35 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $794,550 - $925,809	2,471 New	2,471 $903,000
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $235,248 - $276,215	-844 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $198,078 - $246,161	844 New	844 $242,000

4,003

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.